Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A Refined View on the Association Between Y-chromosome Microdeletions and Sperm Concentration

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Perspectives on a Global Change in Testicular Cancer Incidence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Ejakulationsproblemer

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

Vis graf over relationer

Some trials have shown an overall benefit of low-intensity extracorporeal shockwave therapy (LI-ESWT) for erectile dysfunction, while others have been unable to find differences between LI-ESWT and sham treatment. In the absence of definitive evidence, patients should only be offered LI-ESWT in an investigational setting or on an off-label basis with a thorough understanding of the risks and benefits.

OriginalsprogEngelsk
TidsskriftEuropean Urology Focus
Vol/bind5
Udgave nummer4
Sider (fra-til)526
Antal sider528
ISSN2405-4569
DOI
StatusUdgivet - jul. 2019

Bibliografisk note

Copyright © 2019. Published by Elsevier B.V.

ID: 57420370